Xcelience expanded its GMP manufacturing capabilities with the purchase of three new pieces of equipment for API services for pharmaceutical companies.
“Xcelience is proud to be a service provider that will go the extra mile for our clients,” stated Xcelience president and chief executive officer, Derek G. Hennecke. “Our commitment to quality, decades of drug development experience, and state-of-the-art equipment, combine to accelerate drug development programs and meet critical product and financial milestones.”
“The purchase of the low-volume feeder, the Diosna P1-6 High Shear Granulator, and the Vector LD CS results in the added capability of small batch production to meet customer needs in cases where API is limited. This addition represents our continued commitment to provide cutting edge equipment appropriately scaled to the needs of our clients, and to deliver solutions that save time and money, without compromising quality,” stated director of operations, Ted Koontz.